Category: Approval/Launch Region: Asia · India Company: Zydus Lifesciences Ltd

Zydus Lifesciences Receives FinalUsfda Approval For Pemetrexed AChemotherapy Drug

Zydus Lifesciences Receives FinalUsfda Approval For Pemetrexed AChemotherapy Drug
Pemetrexed Is Used To Treat Certain Types Of Cancers, Such As Lung Cancer And Mesothelioma. It Is A Chemotherapy Drug That Works By Slowing Or Stopping The Growth Of Cancer Cells.Zydus Lifesciences Ltd. Has Received Final Approval From The United States Food And Drug Administration (Us Fda) To Market Pemetrexed A Chemotherapy Drug That Works By Slowing Or Stopping The Growth Of Cancer Cells In The Strengths Of 100 Mg Vial, 500 Mg Vial, And 1000 Mg Vial Singledose Vials (Usrld: Alimta). Pemetrexed Is Used To Treat Certain Types Of Cancers, Such As Lung Cancer And Mesothelioma. The Drug Will Be Manufactured At Zydus Hospira. As Per Iqvia Mat March'22), Pemetrexed For Injection Has A Market Size Of $ 1,236 Mn The Group Now Has 314 Approvals And Has So Far Filed Over 400 Andas Since The Commencement Of The Filing Process In Fy 2003-04.

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!